Bita Geramizadeh1, Scott Robertson2. 1. Department of Pathology, Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. geramib@gmail.com. 2. Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, USA.
Abstract
BACKGROUND: In the past decade, there have been significant changes in the classification and nomenclature of colorectal polyps. Previously, only two groups of lesions were widely recognized, the adenoma and the hyperplastic polyp. Adenomas were considered the only precursor of colorectal cancer, and hyperplastic polyps were considered innocent with no malignant potential. However, recent discoveries about molecular pathways of colorectal cancers have significantly changed our understanding of these neoplasms. Serrated polyps-previously uniformly called hyperplastic polyps-are now known to comprise a heterogeneous family of neoplasms united by their characteristic saw tooth morphology but differing in many important ways, including their malignant potential and molecular profile. This group of neoplasms includes both hyperplastic polyps and the more recently recognized serrated adenomas. Serrated adenomas can be subdivided into the traditional serrated adenoma and the sessile serrated adenoma/polyp. Both of these lesions show characteristic molecular changes, which differ from traditional colorectal adenomatous polyps. OBJECTIVES: In this review, we will discuss the morphologic features of serrated colorectal lesions, the molecular alterations that characterize them, and their role in colorectal cancer development. MATERIAL AND METHODS: The English literature regarding the new nomenclature will be reviewed and the key diagnostic points will be recorded. RESULTS AND DISCUSSION: This large group of polyps has recently been better classified which needs specific attention by pathologists, gastroenterologists and even surgeons.
BACKGROUND: In the past decade, there have been significant changes in the classification and nomenclature of colorectal polyps. Previously, only two groups of lesions were widely recognized, the adenoma and the hyperplastic polyp. Adenomas were considered the only precursor of colorectal cancer, and hyperplastic polyps were considered innocent with no malignant potential. However, recent discoveries about molecular pathways of colorectal cancers have significantly changed our understanding of these neoplasms. Serrated polyps-previously uniformly called hyperplastic polyps-are now known to comprise a heterogeneous family of neoplasms united by their characteristic saw tooth morphology but differing in many important ways, including their malignant potential and molecular profile. This group of neoplasms includes both hyperplastic polyps and the more recently recognized serrated adenomas. Serrated adenomas can be subdivided into the traditional serrated adenoma and the sessile serrated adenoma/polyp. Both of these lesions show characteristic molecular changes, which differ from traditional colorectal adenomatous polyps. OBJECTIVES: In this review, we will discuss the morphologic features of serrated colorectal lesions, the molecular alterations that characterize them, and their role in colorectal cancer development. MATERIAL AND METHODS: The English literature regarding the new nomenclature will be reviewed and the key diagnostic points will be recorded. RESULTS AND DISCUSSION: This large group of polyps has recently been better classified which needs specific attention by pathologists, gastroenterologists and even surgeons.
Authors: Kyoung-Mee Kim; Eui Jin Lee; Sangyun Ha; So Young Kang; Kee-Taek Jang; Cheol Keun Park; Jin Yong Kim; Young Ho Kim; Dong Kyung Chang; Robert Daniel Odze Journal: Am J Surg Pathol Date: 2011-09 Impact factor: 6.394
Authors: Joep E G IJspeert; Barbara A J Bastiaansen; Monique E van Leerdam; Gerrit A Meijer; Susanne van Eeden; Silvia Sanduleanu; Erik J Schoon; Tanya M Bisseling; Manon Cw Spaander; Niels van Lelyveld; Marloes Bargeman; Junfeng Wang; Evelien Dekker Journal: Gut Date: 2015-03-09 Impact factor: 23.059
Authors: Daniel L Edelstein; Marcia Cruz-Correa; Marievelisse Soto-Salgado; Jennifer E Axilbund; Linda M Hylind; Katharine Romans; Cherie Blair; Elizabeth Wiley; Anne C Tersmette; Johan A Offerhaus; Francis M Giardiello Journal: Clin Gastroenterol Hepatol Date: 2015-02-11 Impact factor: 11.382
Authors: Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church Journal: Am J Gastroenterol Date: 2012-06-19 Impact factor: 10.864
Authors: Nicholas G Burgess; Maria Pellise; Kavinderjit S Nanda; Luke F Hourigan; Simon A Zanati; Gregor J Brown; Rajvinder Singh; Stephen J Williams; Spiro C Raftopoulos; Donald Ormonde; Alan Moss; Karen Byth; Heok P'Ng; Duncan McLeod; Michael J Bourke Journal: Gut Date: 2015-03-02 Impact factor: 23.059
Authors: María Belén Novoa Díaz; Pedro Matías Carriere; María Julia Martín; Natalia Calvo; Claudia Gentili Journal: World J Gastroenterol Date: 2021-11-07 Impact factor: 5.742